Účinnost dlouhodobě působících injekcí Risperidonu (Risperdal Consta) v léčbě schizofrenní a achizoafektivní poruchy. Dvouleté výsledky studie E-STAR v České a Slovenské republice

Warning

This publication doesn't include Faculty of Education. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Title in English	Efficacy of risperidone long-term acting injections (Risperdal Consta) in the treatment of schizophrenia and schizoaffective disorders: 2-year results of the e-STAR in the Czech and Slovak Republics
Authors	ČEŠKOVÁ Eva MOHR Pavel PEČEŇÁK Ján ANDERS Martin TŮMA Ivan
Year of publication	2011
Type	Article in Periodical
Magazine / Source	Česká a slovenská psychiatrie
MU Faculty or unit	Central European Institute of Technology
Citation
Field	Psychiatry, sexuology
Keywords	schizophrenia; observational study; risperidone long acting injection; treatment retention; efficacy; tolerability
Description	The authors present 2-years results of e-STAR study in the Czech and Slovak Republic. E-STAR is an multicenter, observational study, focusing on prospective evaluation of the treatment with risperidone long-acting injection in routine clinical praxis. Our data have confirmed a high adherence to the treatment. In spite of this a significant decrease of concomitant medication and a decrease of the illness severity was observed. Our results support the idea, that new formulations of the second generation antipsychotics represent an important advancement in the treatment of psychoses.
Related projects:	The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.